Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection Academic Article uri icon

Overview

MeSH Major

  • Bile Duct Neoplasms
  • Bile Ducts, Intrahepatic
  • Cholangiocarcinoma

abstract

  • At Memorial Sloan-Kettering Cancer Center, IHC incidence has increased dramatically in the last 16 years. Resection offers the best opportunity for long-term survival but is possible in the minority, and patients with large, node-positive or multifocal IHC seem to derive little benefit. Establishing and maintaining control of the intrahepatic disease remains the biggest problem for all IHC patients. The recent increase in survival seems largely because of improved nonoperative therapy for unresectable disease.

publication date

  • July 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/SLA.0b013e318176c4d3

PubMed ID

  • 18580211

Additional Document Info

start page

  • 84

end page

  • 96

volume

  • 248

number

  • 1